The hepatoprotective and anti hepatotoxic effect of Tacazzea barteri was evaluated using carbon tetrachloride (CCL4) induced hepatotoxicity. For the hepatoprotective study, the animals were treated with 200, 400 and 600 mg/kg of T. barteri extract for 7 days prior to the intra peritoneal injection of 1 ml/kg of carbon tetrachloride while for the anti hepatotoxic study; 1 ml/kg of carbon tetrachloride was administered via intra peritoneal route before treatment (2 days). Blood samples were collected from the animals before and after treatment and serum biochemical parameters (AST, ALT, ALP, Bilirubin and Albumin) were determined. The extract showed significant (p < 0.01) reduction in the carbon tetrachloride induced elevation of ALT, AST, ALP and Bilirubin and a significant (p < 0.01) increase in carbon tetrachloride induced suppression of Albumin induction in both models. Histological photomicrographs of liver sections of the untreated groups showed high cellular damage while no visible histological damages were noticed in the extract treated groups in the hepatoprotective model while mild cellular damage was noticed in the anti-hepatotoxic model. The extract not only showed protection of the liver cells against CCL4 hepatotoxin but also showed reversal of hepatic damage cause by CCL4. This study justifies the folkloric use of T. barteri in the treatment of liver diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.